| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
14,274 |
8,750 |
$1.72M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
17,701 |
10,958 |
$1.08M |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
5,951 |
4,039 |
$678K |
| 87634 |
|
14,309 |
8,763 |
$620K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
30,152 |
17,988 |
$578K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
13,567 |
8,791 |
$244K |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
5,385 |
2,573 |
$114K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,075 |
3,512 |
$50K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,030 |
2,992 |
$38K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,923 |
5,604 |
$37K |
| 80053 |
Comprehensive metabolic panel |
4,505 |
3,553 |
$32K |
| 82607 |
|
2,727 |
2,067 |
$25K |
| 83970 |
|
931 |
757 |
$22K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,191 |
3,406 |
$21K |
| 80061 |
Lipid panel |
4,453 |
3,799 |
$19K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
330 |
303 |
$14K |
| 82747 |
|
1,248 |
958 |
$14K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
46 |
45 |
$13K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
118 |
116 |
$13K |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
5,179 |
3,446 |
$12K |
| 83735 |
|
1,875 |
1,489 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
314 |
268 |
$9K |
| 84481 |
|
954 |
802 |
$8K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,303 |
1,005 |
$7K |
| 85610 |
|
2,246 |
572 |
$7K |
| 84100 |
|
2,091 |
1,757 |
$6K |
| 84479 |
|
1,241 |
1,088 |
$6K |
| 84436 |
|
1,105 |
989 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
5,726 |
2,833 |
$6K |
| 87186 |
|
725 |
616 |
$5K |
| 84153 |
|
490 |
421 |
$5K |
| 87088 |
|
643 |
582 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
646 |
590 |
$4K |
| 83550 |
|
533 |
487 |
$3K |
| 83540 |
|
632 |
545 |
$3K |
| 82728 |
|
483 |
414 |
$3K |
| 80076 |
|
515 |
463 |
$3K |
| 87500 |
|
119 |
117 |
$3K |
| 86480 |
|
59 |
55 |
$2K |
| 80050 |
General health panel |
69 |
42 |
$2K |
| 87147 |
|
773 |
638 |
$2K |
| 87210 |
|
536 |
404 |
$2K |
| 87590 |
|
80 |
77 |
$2K |
| 84550 |
|
536 |
486 |
$2K |
| 80184 |
|
242 |
218 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
61 |
59 |
$2K |
| 87640 |
|
61 |
59 |
$2K |
| 81003 |
|
994 |
885 |
$2K |
| 87490 |
|
80 |
77 |
$1K |
| 85652 |
|
506 |
430 |
$1K |
| 87660 |
|
68 |
67 |
$925.10 |
| 87081 |
|
106 |
104 |
$903.73 |
| 87641 |
|
29 |
29 |
$880.78 |
| 87653 |
|
21 |
21 |
$769.88 |
| 80299 |
|
41 |
37 |
$686.39 |
| 87109 |
|
80 |
77 |
$674.65 |
| 87650 |
|
21 |
21 |
$440.10 |
| 80165 |
|
54 |
44 |
$428.75 |
| 86709 |
|
16 |
13 |
$64.21 |